Close

Production & Manufacturing

Sense, Phillips-Medisize partner to speed up production of new COVID-19 test

Sense has announced an accelerated programme to launch the world’s first instrument-free, point-of-care molecular diagnostic test for SARS-CoV-2, the coronavirus responsible for the COVID-19 pandemic. Sense is partnering closely with Phillips-Medisize, a Molex company and leading global medical device innovator,...

Univercells launches cell & gene therapy CMDO Exothera with GMP capabilities in 15,000m2 site in Jumet, Belgium

Univercells has launched a contract development and manufacturing organization (CDMO), Exothera, to support cell and gene therapy developers with process development and production of viral vectors. The company has been created to help alleviate the two most critical challenges...

CDMO to invest over €3m in GMP facility expansion

Spray drying specialist and capsule filling service provider Micro-Sphere is investing 3.5 million CHF (€3.2 million) into expanding its GMP manufacturing capabilities and processes. Micro-Sphere will add an additional spray drying line to its facility in Switzerland in response to...

Sterling Pharma Solutions invests $1.5m into US facility expansion

Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, is investing $1.5m into a phased expansion of its US facility in North Carolina. The investment follows the acquisition of the former US CiVentiChem site earlier this year. Over the...

Covance Unveils New R&D Center in Shanghai

LabCorp, a leading global life sciences company that is deeply integrated in guiding patient care, announced that its Covance Drug Development business celebrated the opening of its new R&D Center in Shanghai, China, which is now its largest facility...

Sharp’s Netherlands Facility Approved for Clinical Operations

Sharp - part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has received Wholesale Distribution Authorisation (WDA) and Investigational Medicinal Product (IMP) licensing approvals to support clinical activities from its facility in Heerenveen,...

Sterling commences large-scale production of Nanologica’s silica particles

Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions has started large-scale production of Nanologica’s silica particles. Nanologica is a nanotechnology company specialising in the development of silica for application in drug development and chromatography. The company recently signed a...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read